JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FOUTS, J. R.
Right arrow Articles by DEVEREUX, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FOUTS, J. R.
Right arrow Articles by DEVEREUX, T. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 183, Issue 2, 458-468, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics


DEVELOPMENTAL ASPECTS OF HEPATIC AND EXTRAHEPATIC DRUG-METABOLIZING ENZYME SYSTEMS: MICROSOMAL ENZYMES AND COMPONENTS IN RABBIT LIVER AND LUNG DURING THE FIRST MONTH OF LIFE

JAMES R. FOUTS 1 and THEODORA R. DEVEREUX 1

1 Pharmacology and Toxicology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina

Rabbit lung microsomes metabolize a variety of chemicals and drugs at rates which are easily measured and often similar to rates using liver microsomes. Age-related changes in liver microsomal enzymes have been studied in detail, but similar studies in lung have not been made to our knowledge. We studied the development of cytochromes, cytochrome reductases and certain drug metabolisms in liver and lung microsomes at four ages: three to five days, two weeks, one month and four to six months (adult). Among the components studied, two general patterns of age-related changes appeared in the hepatic microsomes: 1) a gradual increase from three days to one month and 2) a discontinuous increase with a sharp jump in level between two weeks and one month of age. Reduced nicotinamide adenine dinucleotide phosphate-cytochrome c and P-450 reductase activities and cytochrome b5 content followed the first pattern, whereas cytocimrome P-450 content, benzphetamine metabolism and benzpyrene hydroxylase activity followed the latter pattern. All the components studied in the lung showed a gradual linear increase in level or activity with age. In contrast to the liver, adult cytochrome levels and enzyme activities in lung microsomes were not reached at one month of age. Results suggest that age-related changes in microsomal enzymes occur in both liver and lung, but individual components behave differently in the two tissues. It was shown in both liver and lung that microsomal yield and total enzyme activity could be increased with improved cell breakup (by sonication of homogenates) without affecting enzyme specific activity as measured by benzphetamine metabolism. By comparing benzphetamine metabolism in the homogenates and 9000 x g supernatants in both lung and liver and at all four ages, it was shown that the age-related patterns of enzyme development as determined using only "microsomal" fractions were reasonably representative of the whole organ's development of these xenobiotic metabolizing systems.

Submitted on May 8, 1972
Accepted on July 12, 1972




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. C. Day, C. G. Plopper, and M. V. Fanucchi
Age-specific pulmonary cytochrome P-450 3A1 expression in postnatal and adult rats
Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L75 - L83.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.